Qing Meyerson

Interim CFO, Advisory Board Member at KnoWEwell

Qing has more than 20 years of executive leadership and board service for corporations in the U.S. and China, serving some key industries: automotive, biotech / pharma / healthcare, education, and public accounting. Having served as
• key members of two start-up companies’ leadership team in China and the US, respectively
• one of the leaders of the International Market Legal Entity rationalization and integration for the Bristol Myers Squibb (BMS) – Celgene $75 billion acquisition,
• the Head of Finance and Administration of BMS China/Hong Kong leading the launch of the first immune-oncology cancer drug in China and establishment of new distribution channels, and product life cycle planning and management for mature brands,
• the General Manager and CFO of one of General Motor’s (GM’s) China joint ventures,
• finance leader of multiple deals, brand / product exiting, restructuring, and ERP system, process and control design and implementation,
• lead auditor supporting various clients’ equity and debt offerings, internal control / SOX readiness, and SEC filings,
Qing is accustomed to the rigors of fast-paced, highly regulated environments requiring sharp diligence, accuracy, and outstanding communication skills. Qing is passionate with commitment to serve. She has a track record of successful interacting, communicating, and negotiating with Chinese partners and various government agencies. Qing is also a champion of change with an ability to develop innovative and creative solutions.

During her 13 years in China, Qing also served a range of non-profit organizations:
• Board of Governors of American Chamber of Commerce, Shanghai
• Board member of ATHENA International (USA)
• VP and Board of Director of IPWS (International Professional Women’s Society), a women’s organization in APAC
• Mentor for Mentor Walks in Asia
• Mentor of World Academy for the Future of Women (WAFW)

Start typing and press Enter to search